4/3/2024What To Know About Jiyoutai - China's First Potential Ozempic Challeng...

4/3/2024Chinese ADC Investment Boom in Question With China-U.S. R&D Relations ...

4/2/2024NHC Holds the 2024 National Drug Administration Work Conference

4/2/2024CDE Solicits Comments on the Pharmaceutical Self-Assessment Report for...

4/2/2024Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...

4/2/2024Takeda's Drive: Elevating Chinese Clinical Trials and Global Health

4/1/2024NMPA Announces Package Insert Revision of Metronidazole Injection and ...

4/1/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trial D...

4/1/2024Congress Targets Biotech Suppliers for Pentagon Watchlist Amid China S...

4/1/2024CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...

3/30/2024JPO Launches Follow-On Procurement for the National Level Insulin VBP ...

3/30/2024Drug R&D and Product Registration News Digest March 2024 (4)

3/30/2024Financial-related Company News Digest (March 2024)

3/30/2024Recent Official Changes and Executive Moves

3/30/2024NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...

3/29/2024WuXi AppTec Shared US Client's Data with Beijing (Reuters)

3/29/2024Small Biotechs Reveal Reliance on Chinese CDMOs (BioCentury)

3/29/2024NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...

3/27/2024U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (WSJ...

3/27/2024BIOSECURE Act May Implicate WuXi-Produced Drugs in the US Market

3/27/2024AstraZeneca Plans to Divide Drug Production between US and China Amid ...

3/27/2024NIFDC Issues the 2023 National Drug Sample Inspection Annual Report

3/27/2024NMPA Holds National Conference on Drug Registration and Post-Market Re...

3/27/2024Oncology Partnerships in China Account for 41% of All Deals Over Past ...

3/27/2024China's Primary Healthcare Institutions Handle Over Half of Total Medi...

3/27/2024Mitsui & Rohto-led Consortium Near Deal to Acquire Eu Yan Sang

3/26/2024Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

3/26/2024Big Pharma CEOs Pledge Commitment at China Development Forum 2024

3/26/2024NMPA Publishes the 2023 Annual Report for Adverse Drug Reaction Monito...

3/26/2024AriBio Licenses Alzheimer's Pill in China for Up to $770M

Page:71/777 Total number of articles:23297: [First][<<] [69] [70] [71] [72] [73] [>>] [End]